Does SAQUINAVIR Cause Dyslipidaemia? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Dyslipidaemia have been filed in association with SAQUINAVIR. This represents 1.8% of all adverse event reports for SAQUINAVIR.
14
Reports of Dyslipidaemia with SAQUINAVIR
1.8%
of all SAQUINAVIR reports
0
Deaths
7
Hospitalizations
How Dangerous Is Dyslipidaemia From SAQUINAVIR?
Of the 14 reports, 7 (50.0%) required hospitalization.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SAQUINAVIR. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does SAQUINAVIR Cause?
Lipodystrophy acquired (186)
Eyelid ptosis (169)
Mitochondrial toxicity (165)
Diplopia (161)
Foetal exposure during pregnancy (105)
Dysphagia (103)
Viral mutation identified (82)
Drug resistance (77)
Progressive external ophthalmoplegia (74)
Pathogen resistance (67)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which SAQUINAVIR Alternatives Have Lower Dyslipidaemia Risk?
SAQUINAVIR vs SARECYCLINE
SAQUINAVIR vs SARGRAMOSTIM
SAQUINAVIR vs SARILUMAB
SAQUINAVIR vs SATRALIZUMAB
SAQUINAVIR vs SATRALIZUMAB-MWGE